ArticleIn vivo (Athens, Greece)

Prognostic Value of Serum Tumor Markers in Patients With Stage III NSCLC Treated With Chemoradiotherapy.

Takaaki Tokito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.